Table TDI-12. Characteristics of all women treated for drug problems in 2002 or most recent year available. Part (i) Demographics and injecting status
| Country | Year | Mean age | % Age <25 | % Age 35+ | % Currently injecting any drug | |||
| Belgium | (1) | 1999 | 27.9 | 49 | 25 | 8.8 | ||
| Czech Republic | (2) | 2002 | 21.8 | 79.5 | 4 | 66.6 | ||
| Denmark | 2002 | 32.3 | 26 | 40 | na | |||
| Germany | (4) | 2002 | 26.7 | 49 | 27 | na | ||
| Greece | 2002 | 26.4 | 54.1 | 18.2 | 45.7 | |||
| Spain | (17) | 2002 | 31.2 | 25 | 32 | na | ||
| France | (5) | 1999 | 30.8 | 19.5 | 27.5 | 14.5 | ||
| Ireland | (6) | 2000 | 24.4 | 61.1 | 8.5 | 30.8 | ||
| Italy | (7) | 2002 | 31.8 | 21 | 36.5 | na | ||
| Latvia | (8) | 2002 | 26.9 | 52.5 | 17.4 | na | ||
| Lithuania | 2002 | 32.7 | 41.7 | 24.3 | na | |||
| Luxembourg | 2002 | 30.3 | 23 | 29 | 51 | |||
| Hungary | 2002 | 33.1 | 28 | 38 | na | |||
| Netherlands | (12) | 2002 | 32.6 | 26 | 39 | na | ||
| Austria | (13) | 2002 | 31.8 | 22.2 | 39.1 | 100 | ||
| Slovenia | 2002 | 24.6 | 58.4 | 7.2 | 71.6 | |||
| Slovakia | 2002 | 26.5 | 31.5 | 13.7 | 59.4 | |||
| Finland | 2002 | 24.8 | 64.9 | 13.1 | 59.2 | |||
| Sweden | (15) | 2002 | 33 | 32 | 35 | na | ||
| United Kingdom | (16) | 2002 | 27.6 | 43 | 16 | na | ||
| Notes: | ||||||||
| Data were not available for: Estonia, Cyprus, Malta, Poland and Norway. | ||||||||
| Belgium | (1) | Data refer only to outpatient treatment centres. Last data available refer to 1999. | ||||||
| Czech Republic | (2) | Data refer to all treatment centres. | ||||||
| Germany | (4) | Data only refer to outpatient treatment centres; information about injecting use is not available. | ||||||
| France | (5) | The last available data on treatment demand are reported, referring to the annual census on clients in treatment carried out in November 1999. | ||||||
| Ireland | (6) | Last data available refer to 2000. | ||||||
| Italy | (7) | Data only refer to outpatient treatment centres. | ||||||
| Latvia | (8) | Data refer only to outpatient treatment centres. | ||||||
| Netherlands | (12) | Data refer only to outpatient treatment centres. | ||||||
| Austria | (13) | Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%. | ||||||
| Sweden | (15) | Data refer only to outpatient treatment centres. | ||||||
| United Kingdom | (16) | Data relate to the period from 1 April 2001 to 31 March 2002 for Scotland and Northern Ireland; for England and Wales six months data ending 30 September 2000 plus six months data ending 31 March 2001. | ||||||
| Spain | (17) | Data on men and women only concern outpatient treatment centres. | ||||||
| Sources: 2003 Reitox national reports, Standard table 3, see [Table TDI-10 Part (iii)] for details on sources. | ||||||||
